跳至主要内容
临床试验/NCT01097200
NCT01097200Unknown不适用

Anatomic and Functional Outcomes of Vaginal Mesh ( ELEVATE) Compared With Laparoscopic Sacrocolpopexy for Pelvic Organ Prolapse

Francisco Carmona2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年5月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
Functional and anatomical efficacy

研究概览

简要总结

Pelvic prolapse is one of the most frequent pathology in Gynecology. Recurrency of the prolapse after primary surgery is relatively high, 15-30%. Sacrocolpopexy has showed to be effective but it requires a long learning curves and is more aggressive. New meshes techniques seem to be effective, as well, with less learning curve but they are expensive and there are no randomize studies published.

The investigators aim is to compare both techniques in terms of: anatomical and functional efficacy, cost, operating time and complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subject has been diagnosed with one or more clinically significant anterior, apical, or posterior genital prolapse disorder(s)(symptomatic POP-Q stage II or higher) requiring surgical repair.

排除标准

  • Investigator determines subject is not a candidate for surgical repair of her genital prolapse.
  • Subject has had a prior prolapse procedure involving graft placement (synthetic or biologic)
  • Subject has active or latent systemic infection or signs of tissue necrosis.
  • Subject has restricted leg motion (inability to abduct or adduct leg positioning in the lithotomy position) with or without a hip replacement / prosthesis.
  • Subject is currently pregnant or intends to become pregnant during the study period.
  • Subject has had radiation therapy to the pelvic area.
  • Subject has pelvic cancer, has had pelvic cancer within the past 12 months or has been on cytostatic medication within the past 12 months.
  • Subject has uncontrolled diabetes.
  • Subject is on any medication with could result in compromised immune response, such as immune modulators.
  • Subject has undergone previous pelvic surgery < 6 months prior to enrollment in this study.
  • Subject is unwilling or unable to give valid informed consent.
  • Subject is unwilling or unable to comply with the requirements of the protocol, complete all quality of Life questionnaires and return for all follow-up visits.
  • Subject with contraindications for laparoscopy

结局指标

主要结局

Functional and anatomical efficacy

时间窗: 1 year

次要结局

  • operating time, cost and complications of both techniques(6 months)

研究者

发起方
Francisco Carmona
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Francisco Carmona

Chief of Department of OB GYN

Hospital Clinic of Barcelona

研究点 (2)

Loading locations...

相似试验